5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.

Ka Chang

Managing Director

Zhe Chen

Managing Director

Peter Chen

Managing Director

Yu Cheng

Partner

Lu Huang

Director

Victor Jin

Managing Director

Jiangyun Jin

Managing Director

Ted Xutian Jing

Managing Director

Levi Liu

Partner

Qin Liu

Co-Founder, Investment Director and Board Member

Richard Liu

Founding Partner

Stephanie O'Brien

Investment Professional

Ken Shi

Founding Partner

Yi Sun

Senior Associate

Jerry Tong

Senior Associate

Yunhong Wei

Investor

Yaopeng Xing

Investor

Patricia Zhuoya Yang

Investor

Tony Yeung

Managing Director

Cloris You Youdan

Managing Director

Elwin Yuan

Partner

Yuan Ye

Partner

Fisher Zhang

Partner

Fei Zhang

Partner

Bo Zhang

Managing Director

534 past transactions

Haiper

Seed Round in 2023
Haiper is an artificial intelligence startup focused on transforming computer graphics through innovative technology. The company has developed a platform that enables the creation of photorealistic three-dimensional content using smartphones. By leveraging advanced machine-learning techniques, Haiper offers solutions for 3D reconstruction that require minimal hardware and technical expertise from users. This approach allows customers to easily generate three-dimensional images and models, making the technology accessible to a broader audience.

Evonetix

Series B in 2023
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, established in 2015. The company focuses on developing innovative technology for the parallel synthesis of DNA on silicon arrays, thereby advancing the field of synthetic biology. By employing novel techniques, Evonetix aims to synthesize DNA with higher accuracy and scale, which enhances accessibility for researchers. This platform enables scientists to utilize synthetic biology on a previously unattainable scale, fundamentally changing how DNA is accessed, produced, and utilized for gene synthesis. The engineering team at Evonetix boasts extensive experience in creating high-integrity automated systems, bringing together a diverse range of expertise from various scientific and engineering disciplines to support its mission.

Epigenic

Seed Round in 2022
Epigenic Therapeutics is a biotech firm that offers gene editing therapy.

LANDBASE

Series B in 2022
LANDBASE is a food brand management company driven by the concept of innovation & fashion. Committed to integrating global R&D and production resources, LANDBASE utilizes frontier food processing technologies to redefine traditional foods and build fashionable foods for the future.

Airspace Link

Series B in 2022
Airspace Link, Inc. is a company that specializes in managing local airspace for drones through its enterprise software-as-a-service platform. Founded in 2018 and based in Plymouth, Michigan, the company offers a range of tools designed for various stakeholders. Its AirRegistry platform facilitates the approval of automated drone package deliveries, while AirInspect provides tools for inspecting and approving registered drone delivery sites. AirHub aids in the creation of a comprehensive drone delivery network by mapping flight corridors, no-fly zones, and delivery locations. Additionally, AirLink enables state and local governments to share their regulated airspace with drone delivery services. By digitizing local airspace, Airspace Link supports safe recreational and commercial drone operations, fostering innovation and empowerment among businesses and citizens.

XYZ Robotics

Series B in 2022
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

Hai Robotics

Series D in 2022
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

VisionNav Robotics

Series C in 2022
VisionNav Robotics Limited designs, develops, and manufactures industrial vehicle vision driverless navigation equipment for indoor and outdoor scenes. Its products include vision navigation tray unmanned forklift, visual navigation balance heavy unmanned forklift, vision navigation forward-moving unmanned forklift, visual navigation unmanned tractor, and industrial vehicle driverless system solution. The company serves to e-commerce logistics, aviation logistics, third party logistics, retail fast moving goods, and home appliance sectors. The company was founded in 2015 and is based in Shenzhen, China.

Metis Pharmaceuticals

Series B in 2022
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the movement of new drugs in the pipeline through optimizing pre-clinical trial operations, enabling users to efficiently conduct research and design.

METiS Therapeutics

Series B in 2022
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Eko Health

Series C in 2022
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

SpeedFox

Series A in 2022
Developer of smart cleaning appliances. The company develops a smart cleaning appliance that integrates vacuuming, sweeping, mopping functions into one device, enabling users to clean hard floors such as wood floor and tile floor efficiently in home scenarios.

Cydar Limited

Venture Round in 2022
Cydar Limited develops a fusion imaging software to the healthcare industry. It offers Cydar Medical, a fusion imaging software that delivers automated 3D overlays into the operating room for surgical guidance. The company was incorporated in 2012 and is based in Barrington, United Kingdom with additional office in Wilmington, Delaware.

Regenerative Bio

Angel Round in 2022
Regenerative Bio is a pioneering biotechnology company focused on anti-aging solutions through the integration of artificial intelligence and advanced computing technologies. The company is dedicated to researching and developing ingredients, formulations, and therapies aimed at mitigating the effects of aging and enhancing overall health. By leveraging AI, quantum physics, and high-throughput preparation methods, Regenerative Bio seeks to improve cellular health and energy metabolism, ultimately promoting longer, healthier lives. Their innovative approach combines pharmaceutical technology with biological research, addressing age-related health issues and contributing to the field of longevity science.

Curve Health

Series A in 2022
Curve Health, Inc. is an innovative online platform focused on enhancing senior care through a combination of telemedicine, health information exchange, predictive analytics, and smart billing. Established in 2020 and headquartered in New York, the platform allows physicians to provide remote care to patients in skilled nursing facilities, at home, or during transportation. By integrating these technologies, Curve Health has significantly reduced patient transfers from skilled nursing facilities to emergency departments by over 50%. The platform aims to streamline healthcare delivery, optimize staff allocation, and minimize readmissions while improving care quality and ensuring a seamless patient experience. Additionally, it facilitates efficient communication between hospital systems and post-acute facilities, accelerating reimbursements and enabling effective tracking of patient diagnoses and outcomes.
GreenLight Biosciences is a biotechnology company that specializes in RNA-based solutions for agricultural and pharmaceutical applications. Founded in 2008 and headquartered in Medford, Massachusetts, with an additional location in North Carolina, the company utilizes its Unconstrained Metabolism technology platform to convert renewable substrates into valuable chemicals and fuels. This platform allows for significant flexibility and control in the production process. GreenLight is also focused on developing RNA products aimed at improving crop management, plant protection, and animal health, while advancing vaccine development and pandemic preparedness. In addition to these applications, the company is working on mRNA-based vaccine candidates targeting seasonal and pandemic influenza, as well as other emerging viruses, to enhance public health. Through its innovations, GreenLight aims to provide sustainable solutions that contribute to global food security and health.

Casana

Series B in 2022
Casana is a healthcare technology company focused on heart health monitoring. It has developed the Heart Seat, an innovative product that integrates a toilet seat with a cardiovascular monitoring system. This device allows patients to conveniently track essential heart health metrics such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation from the comfort of their homes. The Heart Seat operates on a cloud-connected platform, enabling seamless data capture and analysis. Founded in 2018 and based in Rochester, New York, Casana aims to enhance heart health monitoring by providing a user-friendly solution that minimizes the need for active patient engagement.

Big Health

Series C in 2022
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

ReviR Therapeutics

Seed Round in 2022
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Virtue Diagnostics

Series B in 2022
Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic company established in 2019 and headquartered in Suzhou, China, with a research and development office in Singapore. The company specializes in developing advanced diagnostic technologies aimed at infectious diseases, cancer, and chronic diseases. Its offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Through these technologies, Virtue Diagnostics aims to enhance disease detection and management, contributing to improved healthcare outcomes.

Parametrix.ai

Series B in 2022
Developer of AI technology to revolutionize game development. The company utilizes AI technology to aid in complex environmental sensing within games, game playing/decision making, creating modeling teams and enemies, and developing player survival/evolution scenarios.

Almond Fintech

Seed Round in 2021
Almond Fintech is a developer of a cross-border payment platform that facilitates remittances and payments across various providers and borders. The company's platform offers currency exchange services and ensures interoperability between mobile wallets and financial services. This enables individuals and businesses to send and receive money using their existing wallets, streamlining the process of cross-border transactions. By focusing on enhancing mobile financial services, Almond Fintech aims to simplify and improve the user experience for both personal and business financial activities.

Treelab

Series A in 2021
Treelab is a Shanghai-based company founded in 2019 that develops a productivity tool designed to empower non-technical users to create customized software solutions without the need for programming expertise. The platform enables individuals and organizations to design and implement various business systems, including project management, sales CRM, form collection, and human resource management. Treelab's software-as-a-service (SaaS) platform offers features such as customer relationship management, competitive analysis, sales pipelining, and project planning. It allows clients to visualize records, compile data, and collaborate in real-time, making it easier for teams to share documents and streamline their processes.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Vastai Technologies

Series B in 2021
Vastai Technologies specializes in the development of semiconductor chips tailored for computer vision, video processing, and various artificial intelligence applications. The company's innovative products are engineered to enhance the computing capabilities of AI visual applications, allowing manufacturers of computer devices to integrate advanced chip technology into their offerings. By focusing on optimizing performance in these specific areas, Vastai Technologies aims to support the growing demand for efficient and powerful AI solutions in the market.

Metis Pharmaceuticals

Series A in 2021
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the movement of new drugs in the pipeline through optimizing pre-clinical trial operations, enabling users to efficiently conduct research and design.

Graphics Origin

Angel Round in 2021
Graphics Origin is a graphics technology company focused on providing advanced productivity tools for 3D content creation.

METiS Therapeutics

Series A in 2021
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Laizanbao Technology

Series A in 2021
Lai Zanbao is a cross-border e-commerce business solution service provider, and its target positioning is a one-stop e-commerce integrated service provider in the Southeast Asian market. Based on past experience and data accumulation in the field of e-commerce and its own international warehousing and distribution system, Lai Zanbao provides merchants in Southeast Asia with a full chain of services from supply chain selection, logistics performance, e-commerce operations to localized marketing.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Moore Threads

Series A in 2021
Moore Threads specializes in the development of graphics processing unit (GPU) technology, catering to a diverse range of sectors including gaming, creative industries, and artificial intelligence. The company provides GPU solutions and services designed to support visual computing and high-performance computing applications. Its offerings are tailored for various environments such as data centers, edge computing servers, professional workstations, and high-performance personal computers. By focusing on enabling clients to execute demanding computational processes, Moore Threads positions itself as a key player in the GPU technology landscape.

Ieso

Series B in 2021
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.

Generate:Biomedicines

Series B in 2021
Generate Biomedicines, Inc. specializes in developing a generative biology platform aimed at inventing novel therapeutic proteins, including antibodies, peptides, enzymes, and other related compounds. Utilizing advanced machine learning techniques, the platform analyzes the genetic code that determines protein function, allowing for the creation of new protein sequences optimized for therapeutic applications. This innovative approach enables the company to generate proteins that interact specifically and effectively with targeted therapeutic needs, facilitating the development of new drugs across various protein modalities. Founded in 2018 and located in Cambridge, Massachusetts, Generate Biomedicines was previously known as Generate Biologics, Inc. until its name change in March 2020.

Zhongke Guosheng

Angel Round in 2021
Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.

Geneoscopy

Series B in 2021
Geneoscopy, LLC is a diagnostic company based in Saint Louis, Missouri, focused on developing non-invasive solutions for gastrointestinal diseases, particularly colorectal cancer. Founded in 2015, Geneoscopy utilizes stool-derived eukaryotic RNA (seRNA) to create a multi-target RNA biomarker panel aimed at identifying colorectal cancer by detecting the effects of cancer-related DNA mutations. The company is committed to improving colorectal cancer screening compliance and facilitating early detection, thereby reducing the associated morbidity and mortality. By employing a novel methodology to extract human RNA transcripts from stool samples, Geneoscopy aims to provide a reliable alternative to traditional colonoscopies, which are often viewed as unpleasant and invasive. In addition to its colorectal cancer diagnostic test, Geneoscopy is also exploring other potential applications of its RNA technology for additional gastrointestinal conditions.

Block Renovation

Series C in 2021
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.

DeepCure

Series A in 2021
DeepCure Inc. offers drugs discovery services using artificial intelligence technology. Its products include De-novo Lead Discovery, Artificial Intelligence-driven Lead Optimization, and MoIDB. De-novo Lead Discovery uses artificial intelligence algorithms to analyze drug candidates from virtual library. Artificial Intelligence-driven Lead Optimization identifies optimization steps to improve the development of drugs. MolDB is designed to maximize scale, diversity, and synthesizability of chemical search space. DeepCure Inc. develops new drug through molecular feature extraction, MoIDB, artificial intelligence predictive modeling and feedback loop. The company was founded in 2018 and is based in Boston, Massachusetts.

Robigo

Pre Seed Round in 2021
Robigo specializes in biopesticide development by engineering the plant microbiome to enhance crop health and mitigate diseases. The company focuses on creating precision microbial treatments that not only improve plant vitality but also help recover lost agricultural yields. Utilizing advanced microbial engineering and data science, Robigo's products are designed to be effective while ensuring safety for beneficial microbes, pollinators, humans, and the broader environment. This approach enables farmers to boost their productivity and profitability while promoting sustainable farming practices.

Huckleberry Labs

Series A in 2021
Huckleberry Labs is focused on enhancing children's sleep by making behavioral expertise accessible and affordable for families. The company has developed an evidence-based program that combines artificial intelligence with human expertise. Their mobile application tracks a child's sleep patterns over a week, providing insights into their sleep conditions. Based on this data, the app offers a straightforward program for parents to help improve their children's sleep habits. Through this innovative approach, Huckleberry Labs aims to support families in addressing sleep challenges effectively.

Moody

Series C in 2021
Moody is a developer of disposable colored contact lenses brand. The company's products are well branded and packaged, as well as hygienic for users, enabling consumers to purchase quality color contact lens products.

Axbio

Series B in 2021
Axbio Inc. is a biotechnology company based in Shenzhen, China, specializing in the development and manufacturing of advanced genetic sequencing technology and diagnostic equipment. Founded in 2016, the company offers a variety of genome extraction kits, including those for stool, blood, saliva, and bacteria. Axbio's product line also encompasses sequencing and diagnostic systems, disposable biochips, and reagents. The company employs semiconductor nanotechnology in its biochips for rapid molecular in-vitro diagnostics and utilizes a microfluidic Bio-CMOS platform for high-throughput sequencing. Axbio's capabilities extend from low-cost handheld devices for bedside diagnostics to fully automated instruments suitable for independent laboratories and hospitals, facilitating services such as early cancer screening, rapid pathogen detection, and drug development. The company is currently operating in stealth mode.

Ailurus Biotechnology

Angel Round in 2021
Developer of biocomputing technology. The company develops synthetic biology platform to improve the efficiency of biotech R&D, making biological product development as simple and efficient as software development.

Signet Therapeutics

Seed Round in 2021
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

PhiGent Robotics

Seed Round in 2021
PhiGent Robotics offers autonomous driving solutions.

EasyExpunctions

Venture Round in 2021
EasyExpunctions.com is a legal platform that offers a cost-effective solution for individuals seeking to erase their criminal records without the need for an attorney. The service employs a unique, patent-pending process that sets it apart from other legal software providers. By focusing exclusively on generating legal documents for reputation management, EasyExpunctions allows users to navigate the expunction process efficiently and affordably. This innovative approach empowers individuals to manage their legal records independently, eliminating the high costs associated with traditional legal services.

HT Aero

Series A in 2021
HT Aero aspires to be the pioneer of urban air mobility (UAM) and is dedicated to producing safe and intelligent electric flying vehicles. which combine automotive and aerospace technologies to realize domestic air-travel usage at scale.

Kappa

Pre Seed Round in 2021
Kappa Pay is a fintech platform that utilizes blockchain technology to streamline payment processes for both local and cross-border transactions. The company aims to provide an affordable and reliable solution for individuals and merchants, facilitating seamless payments that resemble the simplicity of sending a message. By focusing on removing friction and barriers in financial transactions, Kappa enables users to send and receive money globally with higher transaction limits, enhancing the overall efficiency of the payment experience.

BetterUp

Series E in 2021
BetterUp Inc. is a leadership development platform based in San Francisco, California, founded in 2013. The company provides a mobile-based solution for organizations, including Fortune 500 companies, aimed at enhancing employee performance through a science-backed methodology. BetterUp's platform facilitates on-demand virtual coaching sessions, allowing users to identify and practice new behaviors and mindsets essential for achieving high performance in a rapidly changing environment. The platform tracks and measures individual growth, helping employees cultivate skills that support both personal and professional development. Its diverse clientele includes notable companies like Genentech, Logitech, and Workday, reflecting its commitment to fostering an adaptive workforce.

Exo Therapeutics

Series B in 2021
Exo Therapeutics, Inc. is a molecule drug discovery and development company to address intractable pharmaceutical targets. The company develops a pipeline of drug candidates that bind exosites, distal, and unique binding pockets that reprogram enzyme activity for therapeutic effect in oncology, inflammation. Exo Therapeutics, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

HOMEE

Series B in 2021
HOMEE, Inc. is a mobile application company based in Tampa, Florida, that connects homeowners, renters, and property managers with various service providers for home maintenance and improvement needs. Founded in 2016, the platform allows users to easily find and hire local professionals, including handymen, plumbers, electricians, and HVAC specialists, through a GPS-driven interface. The technology streamlines the process of accessing essential services and aims to enhance the overall experience for users by facilitating quick and efficient home service transactions.

Semios

Private Equity Round in 2021
SemiosBio Technologies Inc. offers innovative pest management solutions for growers of tree fruits, nuts, and grapes globally. The company has developed the Semios platform, which enables real-time monitoring and control of agricultural operations through a comprehensive network of sensors. This platform provides continuous coverage and includes features such as automated pheromones, pest traps, and pest pressure notifications, along with frost monitoring and alerts. Additionally, it evaluates disease risk, monitors irrigation, and assesses soil conditions, helping growers make informed decisions to optimize crop quality while reducing agricultural inputs. Founded in 2009 and headquartered in Vancouver, Canada, Semios also operates locations in Fresno, California; Wenatchee, Washington; and Heerlen, the Netherlands.

Hai Robotics

Series C in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Hai Robotics

Series D in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Alamar Biosciences

Series B in 2021
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.

Etern

Series B in 2021
Etern is developing small molecule innovative drugs for oncology therapies.

XtalPi

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company founded in 2014 and headquartered in Cambridge, Massachusetts, with additional offices in China. The company specializes in leveraging artificial intelligence and advanced computing to accelerate drug development. Its offerings include XtalForc, a visual force field calculation software; XtalVision, a tool for crystal structure prediction; and Renova, which supports AI-driven research and development. XtalPi provides a range of services such as crystal structure prediction and determination, solid state testing and analysis, crystallization process development, and small molecule drug design. By collaborating with pharmaceutical companies, XtalPi uses its predictive algorithms to facilitate the development of new drugs and the creation of patents, enhancing the efficiency of the drug discovery process.

OptoGlo

Venture Round in 2021
OptoGlo is a product development company. Our products feature new means of displaying light and color. We license intellectual property and form product distribution companies with our partners. OptoGlo is also a pioneer in the use of nanotechnology to produce transparent illumination and ultra-high-definition displays.

Bota Biosciences

Series B in 2021
Bota Biosciences designs and develops synthetic bioengineering technology platform for bio-manufacturing. The company develops cloud databases and intelligent control software suitable for biotechnology development and production. Bota Biosciences was founded in 2019 and is based in Hangzhou, China.

Medrhythms

Series B in 2021
MedRhythms Inc. is a neuro-rehabilitation company that specializes in neurologic music therapy, utilizing sensors, music, and artificial intelligence to enhance therapeutic outcomes. Founded in 2015 and headquartered in Portland, Maine, the company focuses on patients affected by conditions such as traumatic brain injury, stroke, Parkinson’s disease, and Huntington’s disease. MedRhythms develops evidence-based interventions aimed at improving walking, speech, cognitive abilities, and overall functional outcomes through the intersection of music and neuroscience. By employing innovative technology and direct brain stimulation techniques, the company aims to provide effective rehabilitation solutions that leverage the therapeutic benefits of music for neurological recovery.

Amylyx

Series C in 2021
Amylyx Pharmaceuticals, Inc. develops novel therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. It offers AMX0035, an investigational therapy and a fixed-dose co-formulation of two active compounds, such as sodium phenylbutyrate and Taurursodiol optimized to treat both the energy crisis in the mitochondria and the toxic, unfolded proteins in the endoplasmic reticulum, disrupting the neurological chain of events that leads to patient suffering. The company’s pipeline includes amyotrophic lateral sclerosis, Wolfram syndrome, and Alzheimer’s diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is based in Cambridge, Massachusetts.

XYZ Robotics

Series B in 2021
XYZ Robotics Inc. specializes in automating logistics and manufacturing processes through advanced AI-enabled robotic perception and manipulation technology. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional office in Shanghai, China, the company focuses on developing autonomous robotic solutions for tasks such as sorting and picking. Their robotics systems can efficiently organize random warehouse goods into customer order groups, enhancing supply chain management. By leveraging deep learning and sophisticated robotic manipulation algorithms, XYZ Robotics streamlines operations between batch picking and final packaging, ultimately expediting the order fulfillment process.

Desty

Seed Round in 2021
Desty is a digital platform that serves as a single online destination for creators, influencers, and merchants to promote and sell their products.

Block Renovation

Series B in 2021
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.

Fount Bio

Series A in 2021
Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.

Xiaoice

Series A in 2021
Xiaoice is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Xiaoice allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

neoX BIOTECH

Venture Round in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Linus Health

Series B in 2021
Linus Health is a medical company that concentrates on brain and mental health by using digital technology.

AgileX

Venture Round in 2021
AgileX Robotics (Dongguan) CO., Ltd designs and manufactures mobile robot products. It offers Unmanned ground vehicle (UGV), automated guided vehicle (AGV), and steering-by-wire modified electric vehicles. It serves logistics transportation, security patrolling, and agricultural and animal husbandry industries. The company was founded in 2017 and is based in Dongguan, China with an additional office in Shenzhen, China.

ONES

Series B in 2021
ONES.AI is a technology company specializing in enterprise-level research and development management solutions. Founded in 2015, the company offers a suite of tools designed to enhance project and program management. Its offerings include ONES Project for overseeing project progress, ONES Plan for managing programs, ONES Wiki for repository management, ONES TestCase for managing test cases and plans, and ONES Pipeline for continuous integration and delivery management. ONES.AI has served over 20,000 enterprises and organizations across various sectors, including new retail, gaming, live broadcasting, fintech, and artificial intelligence. The company's platform aims to improve management effectiveness and operational efficiency for its clients.

Triastek

Series B in 2021
Triastek Co. Ltd., founded in 2015 and based in Nanjing, China, specializes in the manufacture of 3D printed pharmaceuticals and related medical equipment. The company offers a range of products, including blockbuster and orphan drugs, as well as complex drug delivery technologies. Triastek develops proprietary 3D printing technology that encompasses the entire process from drug formulation design to continuous production. Its Melt Extrusion Deposition (MED) technology is applicable to solid formulations, enabling innovative drug delivery and development solutions. The company has also filed patent applications for its technologies, emphasizing its commitment to advancing pharmaceutical manufacturing through 3D printing.

Alentis Therapeutics

Series B in 2021
Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Nenly

Funding Round in 2021
Developer of cloud gaming technologies intended to improve entertainment experiences. The company provides cloud gaming services and solutions , dedicating to using advanced cloud tech to enhance gamers' experience across platforms.
Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to developing therapies for diseases associated with mitochondrial dysfunction, which includes both rare genetic disorders and common age-related conditions. The company's lead product candidate, Elamipretide, aims to address these health issues, while additional candidates like SBT-20 and SBT-272 are being explored for their potential benefits in stabilizing mitochondrial function and treating neurodegenerative diseases, respectively. Founded in 2006 and based in George Town, Cayman Islands, Stealth BioTherapeutics collaborates with patients and advocacy groups to deepen its understanding of the challenges faced by those with mitochondrial diseases and to raise awareness of their therapeutic programs.

Huoban

Series B in 2021
Developer of an internal collaborative platform designed to offer small and medium enterprises with sustainable development. The company's internal collaborative platform allows to promote cooperation between employees within the enterprise changes, enabling enterprises to get overall solution for development and operation.

Coin Metrics

Series B in 2021
Coin Metrics Inc. is an online publisher specializing in blockchain and cryptocurrency data, offering a range of market and network analytics to various industries. Founded in 2017 and based in Cambridge, Massachusetts, the company provides several key products, including the CM Network Data Pro, which delivers historical crypto network data in a detailed format for institutional clients. Additionally, Coin Metrics offers the CM Market Data Feed, a standardized solution for trade, candle, and order book data from multiple exchanges, and CM Reference Rates, which provides fixed pricing for various assets quoted in U.S. dollars. By focusing on transparent and actionable data, Coin Metrics enables stakeholders to better understand and utilize public crypto networks.

Catalant

Venture Round in 2021
Catalant Technologies, Inc. is a Boston-based software company that specializes in providing solutions for strategy execution to global enterprises. Founded in 2013 and formerly known as HourlyNerd, the company offers a platform that assists organizations in transforming their strategic objectives into actionable plans. Catalant's software enables businesses to align work, access both internal and external resources, collaborate effectively, and measure the value of their efforts, facilitating faster execution of mission-critical projects. The platform connects enterprises with a global network of over 65,000 experts and more than 27,000 boutique firms, providing a streamlined approach to sourcing expertise on demand. By leveraging best-in-class tools for talent management, Catalant helps clients improve efficiency and effectiveness in achieving their strategic goals.

Hai Robotics

Series B in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

SoupMaster

Series B in 2021
SoupMaster is a Chinese restaurant chain and retail brand. It provides various nutritious soups for pregnant women, patients with a demand for health recuperation, and other people pursuing high-quality life.

Apnimed

Series B in 2021
Apnimed, Inc. is a clinical-stage company based in Cambridge, Massachusetts, focused on developing innovative pharmacologic therapies for sleep apnea and related disorders. Founded in 2017, the company aims to address the significant morbidity and mortality associated with sleep apnea, which affects over 20 million Americans. Apnimed's approach targets the neurobiological mechanisms that lead to airway obstruction, offering a simple, orally dosed treatment option. This strategy contrasts with current therapies, which primarily rely on positive pressure devices like CPAP, as well as other less commonly used methods such as mandibular advancement devices and surgical interventions. Apnimed's therapeutics are designed to alleviate both the physiological and symptomatic effects of obstructive sleep apnea, providing a safe and effective solution that addresses the underlying biology of the condition.

Stavvy

Series A in 2021
Stavvy, Inc. is a financial technology company that specializes in a digital mortgage vendor platform designed to streamline communications and access to vendor data for mortgage banking professionals. The platform offers tools such as Stavvy Connect, which facilitates secure interactions between lenders and their title, settlement, and appraisal vendors, and Stavvy Notarize, which enables real estate professionals to conduct virtual closings and meetings using web conference technology. By eliminating traditional paper processes, Stavvy aims to enhance operational efficiency and compliance while minimizing risks associated with vendor interactions. Founded in 2018 and based in Boston, Massachusetts, the company was formerly known as Stavros Technologies, Inc. before rebranding in August 2020.

PhoreMost

Series B in 2021
PhoreMost Limited, a drug discovery company, engages in identifying new druggable targets for cancer and other unmet diseases. It develops Site-Seeker, a platform that systematically unmasks druggable sites in the human genome and links them to useful therapeutic functions in a live-cell context. The company was incorporated in 2014 and is based in Cambridge, United Kingdom.

Arctic Vision

Series B in 2021
Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a clinical-stage specialty ophthalmology company based in China, focused on developing innovative therapies to meet the unmet clinical needs in ophthalmic diseases. The company has a portfolio of breakthrough technologies aimed at addressing various eye care challenges, including rare diseases through gene therapy. Established by prominent life sciences investors, Arctic Vision is led by a team of experienced professionals from the ophthalmic industry, bringing extensive expertise in research, development, and commercialization of eye care products. The company aims to deliver effective solutions not only in China but also across Asia and globally.

Monument Bank

Series A in 2021
Monument Bank is a bank focus on ‘mass affluent’ clients such as professionals, property investors, and entrepreneurs.

Zhishan Weixin Biotechnology

Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Pony.ai

Series C in 2021
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

neoX BIOTECH

Series A in 2021
neoX BIOTECH is a biotechnology company that develops antigen-based cancer vaccine through a deep understanding of biophysics and the use of artificial intelligence. It develops a neoantigen prediction and TCR screening platform. The company was founded in 2018 and is based in Beijing, China.

Parametrix.ai

Series A in 2021
Developer of AI technology to revolutionize game development. The company utilizes AI technology to aid in complex environmental sensing within games, game playing/decision making, creating modeling teams and enemies, and developing player survival/evolution scenarios.

Rockley Photonics

Venture Round in 2021
Rockley Photonics Limited, founded in 2013 and headquartered in Pasadena, California, specializes in the development of silicon photonics technologies for various applications, including data communications and consumer products. The company manufactures photonic chips and custom integrated packaged products, focusing on both chipset sales and customer-specific designs. Rockley Photonics integrates its research and development efforts to create a comprehensive range of optical modules that include supporting electronics, software, application algorithms, and AI platforms. These offerings are tailored for high-volume applications across dynamic and growing market sectors, demonstrating the company's commitment to innovation in photonics technology.

Liran cosmetics

Series B in 2021
Liran cosmetics operates as a men’s personal care brand. Liran cosmetics provides products catered to men covering skincare, body wash, hair care, body fragrance, and makeup, among others.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.